Shanwaishan released its 2026 interim report on August 28, 2026. During the reporting period, the company achieved total operating revenue of 464 million yuan and net profit attributable to the parent of 94.37 million yuan. Net cash inflow from operating activities was 41.0014 million yuan, down 40.10% from the same period last year. The company's asset-liability ratio was 26.01%, gross margin was 54.67%, return on equity was 5.21%, and diluted earnings per share was 0.30 yuan. In addition, the company had 10,600 shareholders, and the top ten shareholders held a combined 53.43% of total share capital.
SWS Hemodialysis Care Co. Ltd. ACompany released interim report with net profit of 94.37 million yuan, indicating financial performance.